Hyperthermic Isolated Limb Perfusion with TNF α and Cisplatin in the Treatment of Osteosarcoma of the Extremities: A Feasibility Study in Healthy Dogs
Purpose. The feasibility of hyperthermic isolated limb perfusion (HILP) with tumor necrosis factor-α (TNFα ) and cisplatin for the management of osteosarcoma was studied in the canine model.
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
1999-01-01
|
| Series: | Sarcoma |
| Online Access: | http://dx.doi.org/10.1080/13577149977703 |
| id |
doaj-95f7d6d38b64489594cc219c45a1c50d |
|---|---|
| record_format |
Article |
| spelling |
doaj-95f7d6d38b64489594cc219c45a1c50d2020-11-24T20:47:56ZengHindawi LimitedSarcoma1357-714X1369-16431999-01-0132899410.1080/13577149977703Hyperthermic Isolated Limb Perfusion with TNF α and Cisplatin in the Treatment of Osteosarcoma of the Extremities: A Feasibility Study in Healthy DogsRobert J. Van Ginkel0Charles L. H. Van Berlo1Peter C. Baas2Heimen Schraffordt Koops3Ries Van Groningen B. Stuling4Jan Elstrodt5Harald J. Hoekstra6Department of Surgical Oncology, Division of Surgical Oncology, Groningen University Hospital, PO Box 30.001, Groningen 9700 RB, The NetherlandsDepartment of Surgical Oncology, Division of Surgical Oncology, Groningen University Hospital, PO Box 30.001, Groningen 9700 RB, The NetherlandsDepartment of Surgical Oncology, Division of Surgical Oncology, Groningen University Hospital, PO Box 30.001, Groningen 9700 RB, The NetherlandsDepartment of Surgical Oncology, Division of Surgical Oncology, Groningen University Hospital, PO Box 30.001, Groningen 9700 RB, The NetherlandsDepartment of Surgical Oncology, Division of Surgical Oncology, Groningen University Hospital, PO Box 30.001, Groningen 9700 RB, The NetherlandsCentral Animal Laboratory, Groningen University Hospital, Groningen, The NetherlandsDepartment of Surgical Oncology, Division of Surgical Oncology, Groningen University Hospital, PO Box 30.001, Groningen 9700 RB, The NetherlandsPurpose. The feasibility of hyperthermic isolated limb perfusion (HILP) with tumor necrosis factor-α (TNFα ) and cisplatin for the management of osteosarcoma was studied in the canine model.http://dx.doi.org/10.1080/13577149977703 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Robert J. Van Ginkel Charles L. H. Van Berlo Peter C. Baas Heimen Schraffordt Koops Ries Van Groningen B. Stuling Jan Elstrodt Harald J. Hoekstra |
| spellingShingle |
Robert J. Van Ginkel Charles L. H. Van Berlo Peter C. Baas Heimen Schraffordt Koops Ries Van Groningen B. Stuling Jan Elstrodt Harald J. Hoekstra Hyperthermic Isolated Limb Perfusion with TNF α and Cisplatin in the Treatment of Osteosarcoma of the Extremities: A Feasibility Study in Healthy Dogs Sarcoma |
| author_facet |
Robert J. Van Ginkel Charles L. H. Van Berlo Peter C. Baas Heimen Schraffordt Koops Ries Van Groningen B. Stuling Jan Elstrodt Harald J. Hoekstra |
| author_sort |
Robert J. Van Ginkel |
| title |
Hyperthermic Isolated Limb Perfusion with TNF α
and Cisplatin in the
Treatment of Osteosarcoma of the Extremities: A Feasibility Study in
Healthy Dogs |
| title_short |
Hyperthermic Isolated Limb Perfusion with TNF α
and Cisplatin in the
Treatment of Osteosarcoma of the Extremities: A Feasibility Study in
Healthy Dogs |
| title_full |
Hyperthermic Isolated Limb Perfusion with TNF α
and Cisplatin in the
Treatment of Osteosarcoma of the Extremities: A Feasibility Study in
Healthy Dogs |
| title_fullStr |
Hyperthermic Isolated Limb Perfusion with TNF α
and Cisplatin in the
Treatment of Osteosarcoma of the Extremities: A Feasibility Study in
Healthy Dogs |
| title_full_unstemmed |
Hyperthermic Isolated Limb Perfusion with TNF α
and Cisplatin in the
Treatment of Osteosarcoma of the Extremities: A Feasibility Study in
Healthy Dogs |
| title_sort |
hyperthermic isolated limb perfusion with tnf α
and cisplatin in the
treatment of osteosarcoma of the extremities: a feasibility study in
healthy dogs |
| publisher |
Hindawi Limited |
| series |
Sarcoma |
| issn |
1357-714X 1369-1643 |
| publishDate |
1999-01-01 |
| description |
Purpose. The feasibility of hyperthermic isolated limb perfusion
(HILP) with tumor necrosis factor-α (TNFα ) and cisplatin for the management of
osteosarcoma was studied in the canine model. |
| url |
http://dx.doi.org/10.1080/13577149977703 |
| work_keys_str_mv |
AT robertjvanginkel hyperthermicisolatedlimbperfusionwithtnfaandcisplatininthetreatmentofosteosarcomaoftheextremitiesafeasibilitystudyinhealthydogs AT charleslhvanberlo hyperthermicisolatedlimbperfusionwithtnfaandcisplatininthetreatmentofosteosarcomaoftheextremitiesafeasibilitystudyinhealthydogs AT petercbaas hyperthermicisolatedlimbperfusionwithtnfaandcisplatininthetreatmentofosteosarcomaoftheextremitiesafeasibilitystudyinhealthydogs AT heimenschraffordtkoops hyperthermicisolatedlimbperfusionwithtnfaandcisplatininthetreatmentofosteosarcomaoftheextremitiesafeasibilitystudyinhealthydogs AT riesvangroningenbstuling hyperthermicisolatedlimbperfusionwithtnfaandcisplatininthetreatmentofosteosarcomaoftheextremitiesafeasibilitystudyinhealthydogs AT janelstrodt hyperthermicisolatedlimbperfusionwithtnfaandcisplatininthetreatmentofosteosarcomaoftheextremitiesafeasibilitystudyinhealthydogs AT haraldjhoekstra hyperthermicisolatedlimbperfusionwithtnfaandcisplatininthetreatmentofosteosarcomaoftheextremitiesafeasibilitystudyinhealthydogs |
| _version_ |
1716809573641224192 |